Application of semiliquidambar cathayensis or semiliquidambar cathayensis extract in preparation of anti-cerebral ischemia drugs
A technology of anti-cerebral ischemia and Banfenghe, which is applied in the direction of drug combination, medical formula, plant raw materials, etc., to improve neurological function, reduce the size of cerebral infarction, and facilitate administration
Pending Publication Date: 2022-06-10
GUANGXI INST OF CHINESE MEDICINE & PHARMA SCI
View PDF8 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
The existing literature shows that Banfenghe has rich pharmacological activities, and can be used to prepare drugs for anti-hepatitis B virus, promoting blood circulation and removing blood stasis, anti-inflammatory and analgesic, and treating osteoarthritis. At present, there are no related reports
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0032] drug test
[0033] Approach:
Embodiment 2
[0034] (1) Neurobehavioral score
[0035] Result: if Figure 1-3 As shown, compared with the sham operation group, the neurobehavioral score, cerebral infarction rate and brain water content of rats in the model group were significantly increased ( P P P P P P P Figure 4 shown. Note: ## P ** P ** P <0.01 vs. model group.
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention discloses application of semiliquidambar cathayensis or an extract of the semiliquidambar cathayensis in preparation of an anti-cerebral ischemia drug, the semiliquidambar cathayensis is a dry root of hamamelis hamamelis H.T.Chang., the extract of the semiliquidambar cathayensis is an aqueous extract of the semiliquidambar cathayensis or an organic solvent extract of the semiliquidambar cathayensis, and an extraction method of the extract of the semiliquidambar cathayensis comprises the following steps: taking the semiliquidambar cathayensis; adding a solvent for soaking treatment, then heating for extraction, combining liquid medicine extracted for multiple times, and concentrating to obtain the traditional Chinese medicine composition. It is found for the first time that the semiliquidambar cathayensis or the extract of the semiliquidambar cathayensis has the obvious effect of relieving cerebral ischemia injury, the semiliquidambar cathayensis or the extract of the semiliquidambar cathayensis has the patent medicine potential of preparing the medicine preparation for preventing or treating cerebral ischemia and related diseases, and the preparation method of the medicine preparation is simple, low in cost and good in
Description
technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to the application of a kind of maple lotus or its extract in the preparation of anti-cerebral ischemia medicine. Background technique [0002] Stroke includes ischemic stroke and hemorrhagic stroke, and ischemic stroke accounts for about 60%-80%. Ischemic stroke is a focal brain dysfunction caused by insufficient or interrupted local cerebral blood supply, oxygen supply, etc. The disease is a common clinical critical illness and frequently-occurring disease, often with a poor prognosis and high morbidity, disability and mortality. At present, there is still no effective method to treat or delay cerebral ischemic injury. Ischemia-reperfusion injury (IRI) refers to the pathological phenomenon in which tissue damage is aggravated after a certain period of ischemia and blood supply is restored. The brain tissue hypoxia and ischemia-reperfusion caused ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/185A61P9/10A61K125/00
CPCA61K36/185A61P9/10A61K2236/331A61K2236/39A61K2236/51A61K2236/333
Inventor 韦洁何俊慧方伟蓉李冬梅韦桂宁韦冬梅李懿
Owner GUANGXI INST OF CHINESE MEDICINE & PHARMA SCI
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com